Date: 2016-03-11
Type of information: Company acquisition
Acquired company: ams Laboratories (Australia)
Acquiring company: Eurofins Scientific (Luxembourg)
Amount: undisclosed
Terms: * On March 11, 2016, Eurofins Scientific, a leader in biopharmaceutical products testing, announced its entry into the biopharmaceutical products testing market in the Asia Pacific region with the acquisition of ams Laboratories, the leading independent analytical and cGMP Quality Control services provider for biopharmaceutical products and medical devices in Australia. The acquisition of ams Laboratories provides Eurofins with a strong entry platform to deploy its market-leading biopharmaceutical testing capabilities to support the pharmaceutical and biotechnology industries in the Asia Pacific region. Furthermore, it allows Eurofins to expand into medical device testing in the region, which is entirely complementary to its existing biopharma capabilities. The company therefore presents an excellent geographical and operational fit for the Group. ams Laboratories further expands the Eurofins global biopharma service offering, and will enable the Group to further leverage its existing client relationships in Europe and North America, and accelerate its expanding client reach in Asia Pacific, which still represents a vast potential growth market for drug development.
Details: Founded 20 years ago, ams Laboratories is one of the top three, and the largest pure-play biopharmaceutical products testing provider in the Australian market, serving the biopharma and medical devices industries. The company employs 45 staff across its 2 sites in Sydney and Brisbane. ams Laboratories has generated revenues in excess of € 5m for the fiscal year 2015, the majority of which is from biopharmaceutical products testing. The company is also active in medical device testing, as well as in probiotics and nutraceutical testing.
Related: Analytical services
